The IPOPHL said in a statement on Sunday that Memorandum Circular 2022-007 was issued on Jan. 24, authorizing the program for PCT registrants.
“With the continued reopening of the economy, we hope to encourage more inventors and companies to seek global opportunities,” IPOPHL Director General Rowel S. Barba said. “An ISR identifies the existing patents and prior art which may affect an invention’s patentability. Meanwhile, an IPER is an initial assessment of an application’s novelty, inventive step and industrial applicability prepared according to international standards. Both reports help an applicant evaluate the chances of the invention being patented under the PCT,” IPOPHL said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: